Risk of subsequent malignant neoplasms among 1,641 Hodgkin's disease patients diagnosed in childhood and adolescence: A population-based cohort study in the five Nordic countries

Journal of Clinical Oncology

Volumn 14, Issue 5, 1996, Pages 1442-1446

  Sankila, R ^a   Garwicz, S ^a   Olsen, J H ^a   Dollner H ^a   Hertz, H ^a   Kreuger, A ^a   Langmark, F ^a   Lanning, M ^a   Moller T ^a   Tulinius, H ^a  

^a FINNISH CANCER REGISTRY   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER RISK; CHILD; DENMARK; FEMALE; FINLAND; HODGKIN DISEASE; HUMAN; ICELAND; INFANT; LEUKEMIA; MAJOR CLINICAL STUDY; MALE; NORWAY; PRIORITY JOURNAL; SWEDEN; THYROID CANCER;

EID: 9244260174     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1996.14.5.1442     Document Type: Article

References (20)

1. Tucker MA, Meadows AT, Boice JD Jr, et al: Leukemia after therapy with alkylating agents for childhood cancer. J Natl Cancer Inst 78:459-464, 1987
2. Kushner BH, Zauber A, Tan CTC: Second malignanies after childhood Hodgkin's disease. The Memorial Sloan-Kettering Cancer Center experience. Cancer 62:1364-1370, 1988
3. Meadows AT, Obringer AC, Marrero O, et al: Second malignant neoplasms following childhood Hodgkin's disease: Treatment and splenectomy as risk factors. Med Pediatr Oncol 17:477-484, 1989
4. Tarbell NJ, Gelber RD, Weinstein HJ, et al: Sex differences in risk of second malignant tumours after Hodgkin's disease in childhood. Lancet 341:1428-1432, 1993
5. Rosso P, Terracini B, Fears TR, et al: Second malignant tumors after elective end of therapy for a first cancer in childhood: A multicenter study in Italy. Int J Cancer 59:451-456, 1994
6. Beaty O III, Hudson MM, Greenwald C, et al: Subsequent malignancies in children and adolescents after treatment for Hodgkin's disease. J Clin Oncol 13:603-609, 1995
7. Shapiro CL, Mauch PM: Radiation-associated breast cancer after Hodgkin's disease: Risks and screening in perspective. J Clin Oncol 10:1662-1665, 1992 (editorial)
8. Grünwald HW, Rosner F: Acute myeloid leukemia following treatment of Hodgkin's disease. A review. Cancer 50:676-683, 1982
9. Henry-Amar M, Dietrich P-Y: Acute leukemia after the treatment of Hodgkin's disease. Hematol Oncol Clin North Am 7:369-387, 1993
10. Hancock S, Tucker MA, Hoppe RT: Breast cancer after treatment of Hodgkin's disease. J Natl Cancer Inst 85:25-31, 1993
11. Tucker MA, Meadows AT, Boice JD Jr, et al: Cancer risk following treatment of childhood cancer, in Boice JD Jr, Fraumeni JF Jr (eds): Radiation Carcinogenesis: Epidemiology and Biological Significance. New York, NY, Raven, 1984, pp 211-224
12. Tulinius H, Storm HH, Pukkala E, et al: Cancer in the Nordic countries, 1981-86. Acta Pathol Microbiol Immunol Scand 100:3-8, 1992 (suppl 38)
13. Teppo L, Pukkala E, Lehtonen M: Data quality and quality control of a population-based cancer registry. Acta Oncol 33:365-369, 1994
14. Olsen JH, Garwicz S, Hertz H, et al: Second malignant neoplasms after cancer in childhood or adolescence. Br Med J 307:1030-1036, 1993
15. Diem K (ed): Documenta Geigy Wissenschaftlige Tabellen, (ed 6). Basel, Switzerland, Geigy, 1960, p 107
16. van Leeuwen FE, Klokman WJ, Hagenbeek A, et al: Second cancer risk following Hodgkin's disease: A 20-year follow-up study. J Clin Oncol 12:312-325, 1994
17. Hancock SL, Cox RS, McDougall IR: Thyroid diseases after treatment of Hodgkin's disease. N Engl J Med 325:599-605, 1991
18. Vallagussa P, Santoro A, Fossati-Bellani F, et al: Second acute leukemia and other malignancies following treatment for Hodgkin's disease. J Clin Oncol 4:830-837, 1986
19. Pedersen-Bjergaard J, Specht L, Larsen SO, et al: Risk of therapy-related leukaemia and preleukaemia after Hodgkin's disease. Lancet 2:83-88, 1987
20. Blayney DW, Longo DL, Young RC, et al: Decreasing risk of leukemia with prolonged follow-up after chemotherapy and radiotherapy for Hodgkin's disease. N Engl J Med 316:710-714, 1987